Back to Agenda
CLOSING
Session Chair(s)
Miyoko Yamauchi
Clinical Leader, Specialty Clinical Development Dept., CHUGAI PHARMACEUTICAL CO., LTD., Japan
Speaker(s)
Haruko Yamamoto, MD, PhD
Executive Director, National Cerebral and Cardiovascular Center, Japan
Have an account?